Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Completed · Phase 2

Conditions studied: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Thymic Carcinoma

In brief

RATIONALE: Umbilical cord blood transplantation may be able to replace cells destroyed by chemotherapy or radiation therapy. PURPOSE: Phase II trial to study the effectiveness of umbilical cord blood transplantation in treating patients who have hematologic cancer or other hematologic or metabolic diseases.

Key facts

Study ID
NCT00003662
Run by
Roswell Park Cancer Institute
People needed
90
Starts
1998-08-01
Expected to finish
2001-01-01
Last updated by the study team
2011-03-07

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.